Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Predicting 15-year prostate cancer specific mortality after radical prostatectomy.
Eggener SE, Scardino PT, Walsh PC, Han M, Partin AW, Trock BJ, Feng Z, Wood DP, Eastham JA, Yossepowitch O, Rabah DM, Kattan MW, Yu C, Klein EA, Stephenson AJ.
J Urol. 2011 Mar;185(3):869-75. doi: 10.1016/j.juro.2010.10.057. Epub 2011 Jan 15.
Similar articles
Characterization of the primate luteinizing hormone receptor in testis homogenates and Leydig cells.
Davies TF, Walsh PC, Hodgen GD, Dufau ML, Catt KJ.
J Clin Endocrinol Metab. 1979 Apr;48(4):680-5. No abstract available.
Effects of hormones in the newborn period on the development of the penis.
Rajfer J, Coffey DS, Walsh PC.
Surg Forum. 1977;28:570-3. No abstract available.
The measurement of androgen receptors in human prostatic tissue utilizing sucrose density centrifugation and a protamine precipitation assay.
Menon M, Tananis CE, McLoughlin MG, Lippman ME, Walsh PC.
J Urol. 1977 Mar;117(3):309-12.
Sonography in the diagnosis of retroperitoneal fibrosis.
Sanders RC, Duffy T, Mcloughlin MG, Walsh PC.
J Urol. 1977 Dec;118(6):944-6.
Clinical and endocrinologic characterization of a patients with the syndrome of incomplete testicular feminization.
Madden JD, Walsh PC, MacDonald PC, Wilson JD.
J Clin Endocrinol Metab. 1975 Oct;41(4):751-60.
The value of serum enzymatic acid phosphatase in the staging of localized prostate cancer.
Burnett AL, Chan DW, Brendler CB, Walsh PC.
J Urol. 1992 Dec;148(6):1832-4.
Why make an early diagnosis of prostate cancer.
Walsh PC.
J Urol. 1992 Mar;147(3 Pt 2):853-4. No abstract available.
The management of rectal injury during radical retropubic prostatectomy.
Borland RN, Walsh PC.
J Urol. 1992 Mar;147(3 Pt 2):905-7.
Correlation of prostate cancer nuclear deoxyribonucleic acid, size, shape and Gleason grade with pathological stage at radical prostatectomy.
Epstein JI, Pizov G, Steinberg GD, Carter HB, Pitcock R, Armas OA, Partin A, Walsh PC.
J Urol. 1992 Jul;148(1):87-91. Review.
Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia.
Partin AW, Carter HB, Chan DW, Epstein JI, Oesterling JE, Rock RC, Weber JP, Walsh PC.
J Urol. 1990 Apr;143(4):747-52.
Clinical and experimental studies of benign prostatic hyperplasia.
Coffey DS, Walsh PC.
Urol Clin North Am. 1990 Aug;17(3):461-75. Review.
The relationship of prostate specific antigen levels and residual tumor volume in stage A prostate cancer.
Carter HB, Partin AW, Epstein JI, Chan DW, Walsh PC.
J Urol. 1990 Nov;144(5):1167-70; discussion 1170-1.
Management of stage D1 adenocarcinoma of the prostate: the Johns Hopkins experience 1974 to 1987.
Steinberg GD, Epstein JI, Piantadosi S, Walsh PC.
J Urol. 1990 Dec;144(6):1425-32.
Influence of age and endocrine factors on the volume of benign prostatic hyperplasia.
Partin AW, Oesterling JE, Epstein JI, Horton R, Walsh PC.
J Urol. 1991 Feb;145(2):405-9.
Effect of reversible androgen deprivation on hemoglobin and serum immunoreactive erythropoietin in men.
Weber JP, Walsh PC, Peters CA, Spivak JL.
Am J Hematol. 1991 Mar;36(3):190-4.
Cancer control following anatomical radical prostatectomy: an interim report.
Morton RA, Steiner MS, Walsh PC.
J Urol. 1991 Jun;145(6):1197-200.
Impact of anatomical radical prostatectomy on urinary continence.
Steiner MS, Morton RA, Walsh PC.
J Urol. 1991 Mar;145(3):512-4; discussion 514-5.
Needle biopsy associated tumor tracking of adenocarcinoma of the prostate.
Bastacky SS, Walsh PC, Epstein JI.
J Urol. 1991 May;145(5):1003-7.
Sexual function following radical prostatectomy: influence of preservation of neurovascular bundles.
Quinlan DM, Epstein JI, Carter BS, Walsh PC.
J Urol. 1991 May;145(5):998-1002.
Filters: Manage Filters